Medical Countermeasures: Long-Term Funding Could Spur More Development Work
Executive Summary
Chimerix CEO tells Congress allocating Project Bioshield a multi-year funding stream would provide more long-term certainty for countermeasure sponsors.
You may also be interested in...
Outgoing Merck CEO Touts COVID Innovations, But Worries Pandemic Prep May Lack Staying Power
Ken Frazier says advocates need to ensure governments continue investing in global biosecurity.
Biodefense Bill Moving In Senate; Still Debate Over Best Approach For Flu
US Pandemic and All Hazards Preparedness Act appears on track for on-time reauthorization – but there may still be debate over whether and how to dedicate funding specifically for pandemic flu preparedness and stockpiling.
Drug Shortage Legislation Possible As US FDA Seeks New Powers To Prevent Problems
Commissioner Gottlieb proposes new authorities that could require manufacturers of certain drugs to establish risk mitigation plans to avert potential drug shortages.